UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

Transplantation proceedings, 2001-05, Vol.33 (3), p.2121-2123

2001

Volltextzugriff (PDF)

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients

Clinical transplantation, 2000-04, Vol.14 (2), p.121-126

2000

Volltextzugriff (PDF)

Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience

Bone marrow transplantation (Basingstoke), 2002-11, Vol.30 (10), p.651-659

2002

Volltextzugriff (PDF)

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant

Bone marrow transplantation (Basingstoke), 2000, Vol.25 (1), p.41-45

2000

Volltextzugriff (PDF)

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors

Clinical transplantation, 2007-01, Vol.21 (1), p.110-116

2007

Volltextzugriff (PDF)

Excited-state proton transfer in 2-(2'-hydroxyphenyl)benzothiazole: formation of the anion in polar solvents

Chemical physics letters, 1987-10, Vol.140 (3), p.293-299

1987

Volltextzugriff (PDF)

Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors : results of a single-center study

Bone marrow transplantation (Basingstoke), 2001, Vol.27 (1), p.27-33

2001

Volltextzugriff (PDF)

Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors : an open label randomized split dose escalating study

Bone marrow transplantation (Basingstoke), 2000-02, Vol.25 (4), p.371-376

2000

Volltextzugriff (PDF)

Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants

Thrombosis and haemostasis, 1999-12, Vol.82 (6), p.1771-1772

1999

Volltextzugriff (PDF)

Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation

Leukemia & lymphoma, 1998-12, Vol.32 (1-2), p.189-193

1998

Volltextzugriff (PDF)

Excited-state proton transfer in 2-(2′-hydroxyphenyl)benzothiazole: Transient electronic absorption measured on the picosecond time scale

Chemical physics letters, 1988-07, Vol.148 (2), p.112-118

1988

Volltextzugriff (PDF)

Non-myeloablative stem cell transplants: Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience

Bone marrow transplantation (Basingstoke), 2002, Vol.30 (10), p.651-659

2002

Volltextzugriff (PDF)

Eosinophilia in bone marrow after hematopoetic stem cell transplantation: does it indicate the onset of acute graft-versus-host disease?

European journal of cancer (1990), 2001-04, Vol.37, p.S98-S98

2001

Volltextzugriff (PDF)

Genotoxic effects of 2- trans-hexenal in human buccal mucosa cells in vivo

Mutation research, 1997-04, Vol.390 (1), p.161-165

1997

Volltextzugriff (PDF)

Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation

Leukemia & Lymphoma, 1998, Vol.32 (1-2), p.189-193

1998

Volltextzugriff (PDF)

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy

International journal of molecular sciences, 2019-01, Vol.20 (3), p.482

2019

Volltextzugriff (PDF)

P07.02 Control leukemia by inducing anti-cancer immune reactivity in vivo? – Potential of a DC-triggered mechanism

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A25-A25

2022

Volltextzugriff (PDF)

Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers

European journal of cancer (1990), 2019-03, Vol.110, p.S28-S29

2019

Volltextzugriff (PDF)

P475: CONTROL LEUKEMIA BY INDUCING ANTI‐CANCER IMMUNE REACTIVITY IN VIVO? POTENTIAL OF A DC‐TRIGGERED MECHANISM

HemaSphere, 2022-06, Vol.6, p.374-375

2022

Volltextzugriff (PDF)

Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells

European journal of cancer (1990), 2018-03, Vol.92, p.S15-S15

2018

Volltextzugriff (PDF)

P01.10 IFNy secretion of adaptive and innate immune cells as a parameter to display leukaemia derived dendritic cell (DCleu) mediated immune responses in AML

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A13-A13

2020

Volltextzugriff (PDF)

Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017

Journal for immunotherapy of cancer, 2017-03, Vol.5 (S1), Article 12

2017

Volltextzugriff (PDF)

Evaluation of Antipsychotic and Concomitant Medication Use Patterns in Patients with Schizophrenia

Medical care, 1999-04, Vol.37 (4), p.AS81-AS86

1999

Volltextzugriff (PDF)

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1 TH2 polarization

Gene therapy, 2004-07, Vol.11 (13), p.1048-1056

2004

Volltextzugriff (PDF)

Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes

Annals of hematology, 2000-01, Vol.79 (1), p.20-29

2000

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients

Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors

Excited-state proton transfer in 2-(2'-hydroxyphenyl)benzothiazole: formation of the anion in polar solvents

Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors : results of a single-center study

Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors : an open label randomized split dose escalating study

Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants

Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation

Excited-state proton transfer in 2-(2′-hydroxyphenyl)benzothiazole: Transient electronic absorption measured on the picosecond time scale

Non-myeloablative stem cell transplants: Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience

Eosinophilia in bone marrow after hematopoetic stem cell transplantation: does it indicate the onset of acute graft-versus-host disease?

Genotoxic effects of 2- trans-hexenal in human buccal mucosa cells in vivo

Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy

P07.02 Control leukemia by inducing anti-cancer immune reactivity in vivo? – Potential of a DC-triggered mechanism

Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers

P475: CONTROL LEUKEMIA BY INDUCING ANTI‐CANCER IMMUNE REACTIVITY IN VIVO? POTENTIAL OF A DC‐TRIGGERED MECHANISM

Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells

P01.10 IFNy secretion of adaptive and innate immune cells as a parameter to display leukaemia derived dendritic cell (DCleu) mediated immune responses in AML

Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017

Evaluation of Antipsychotic and Concomitant Medication Use Patterns in Patients with Schizophrenia

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1 TH2 polarization

Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes

Suchergebnisse filtern